NEW YORK (GenomeWeb News) - Integromics, a bioinformatics company based in Granada and Madrid, has signed a North American marketing agreement with Discovery Scientific, the companies said today.
Under the terms of the agreement, Discovery Scientific will market Integromics’ genomic and proteomic data management and analysis software and LIMS solution to clients in the Northwestern US and Canada.
Integromics called the agreement a "critical component" in its global strategy.
Financial terms of the agreement were not released.